About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Foxn1tm1.1Dmsu
targeted mutation 1.1, Dong-Ming Su
MGI:4454641
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu involves: 129/Sv * C57BL/6 * SJL MGI:4454656
cn2
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
involves: 129/Sv * C57BL/6 * CBA * SJL MGI:4454657
cn3
Foxn1nu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
involves: 129/Sv * C57BL/6 * CBA * SJL MGI:4454658
cn4
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(KRT18-cre/ERT2)1Rgo/0
involves: 129/Sv * C57BL/6 * FVB/N * SJL MGI:4454660
cn5
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(KRT5-cre/ERT2)2Ipc/0
involves: 129/Sv * C57BL/6 * SJL MGI:4454659


Genotype
MGI:4454656
hm1
Allelic
Composition
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Genetic
Background
involves: 129/Sv * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxn1tm1.1Dmsu mutation (1 available); any Foxn1 mutation (106 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are normal




Genotype
MGI:4454657
cn2
Allelic
Composition
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
Genetic
Background
involves: 129/Sv * C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxn1tm1.1Dmsu mutation (1 available); any Foxn1 mutation (106 available)
Tg(CAG-cre/Esr1*)5Amc mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Thymic atrophy in tamoxifen treated Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu Tg(KRT5-cre/ERT2)2Ipc/0 mice and Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu Tg(CAG-cre/Esr1*)5Amc/0 mice

immune system
• following tamoxifen treatment, mice exhibit a decrease in thymic stromal cells compared to in wild-type mice
• following tamoxifen treatment
• following tamoxifen treatment
• following tamoxifen treatment
• following tamoxifen treatment

hematopoietic system
• following tamoxifen treatment, mice exhibit a decrease in thymic stromal cells compared to in wild-type mice
• following tamoxifen treatment
• following tamoxifen treatment
• following tamoxifen treatment
• following tamoxifen treatment

endocrine/exocrine glands
• following tamoxifen treatment, mice exhibit a decrease in thymic stromal cells compared to in wild-type mice
• following tamoxifen treatment
• following tamoxifen treatment
• following tamoxifen treatment




Genotype
MGI:4454658
cn3
Allelic
Composition
Foxn1nu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
Genetic
Background
involves: 129/Sv * C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxn1nu mutation (43 available); any Foxn1 mutation (106 available)
Foxn1tm1.1Dmsu mutation (1 available); any Foxn1 mutation (106 available)
Tg(CAG-cre/Esr1*)5Amc mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• following tamoxifen treatment, mature medullary thymic epithelial cells undergo increased apoptosis compared to in wild-type mice
• following tamoxifen treatment, medullary thymic epithelial cells are reduced compared to in wild-type mice
• mature medullary thymic epithelial cells are more affected than presumptive medullary thymic epithelial cell precursors following tamoxifen treatment
• however, cortical thymic epithelial cells are not significantly reduced following tamoxifen treatment
• following tamoxifen treatment

hematopoietic system
• following tamoxifen treatment, mature medullary thymic epithelial cells undergo increased apoptosis compared to in wild-type mice
• following tamoxifen treatment, medullary thymic epithelial cells are reduced compared to in wild-type mice
• mature medullary thymic epithelial cells are more affected than presumptive medullary thymic epithelial cell precursors following tamoxifen treatment
• however, cortical thymic epithelial cells are not significantly reduced following tamoxifen treatment
• following tamoxifen treatment

cellular
• following tamoxifen treatment, mature medullary thymic epithelial cells undergo increased apoptosis compared to in wild-type mice

endocrine/exocrine glands
• following tamoxifen treatment, mature medullary thymic epithelial cells undergo increased apoptosis compared to in wild-type mice
• following tamoxifen treatment, medullary thymic epithelial cells are reduced compared to in wild-type mice
• mature medullary thymic epithelial cells are more affected than presumptive medullary thymic epithelial cell precursors following tamoxifen treatment
• however, cortical thymic epithelial cells are not significantly reduced following tamoxifen treatment
• following tamoxifen treatment




Genotype
MGI:4454660
cn4
Allelic
Composition
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(KRT18-cre/ERT2)1Rgo/0
Genetic
Background
involves: 129/Sv * C57BL/6 * FVB/N * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxn1tm1.1Dmsu mutation (1 available); any Foxn1 mutation (106 available)
Tg(KRT18-cre/ERT2)1Rgo mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• following tamoxifen treatment, mice exhibit normal thymus size, profile of CD4 versus CD8 cells, thymic epithelial cell numbers, and thymic architecture




Genotype
MGI:4454659
cn5
Allelic
Composition
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(KRT5-cre/ERT2)2Ipc/0
Genetic
Background
involves: 129/Sv * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxn1tm1.1Dmsu mutation (1 available); any Foxn1 mutation (106 available)
Tg(KRT5-cre/ERT2)2Ipc mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Thymic atrophy in tamoxifen treated Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu Tg(KRT5-cre/ERT2)2Ipc/0 mice and Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu Tg(CAG-cre/Esr1*)5Amc/0 mice

immune system
• following tamoxifen treatment, the medullary region architecture is altered and the corticomedullary junction becomes indistinct compared to in wild-type mice
• following tamoxifen treatment, the medullary region architecture is altered and the corticomedullary junction becomes indistinct compared to in wild-type mice
• following tamoxifen treatment
• following tamoxifen treatment
• following tamoxifen treatment

hematopoietic system
• following tamoxifen treatment, the medullary region architecture is altered and the corticomedullary junction becomes indistinct compared to in wild-type mice
• following tamoxifen treatment, the medullary region architecture is altered and the corticomedullary junction becomes indistinct compared to in wild-type mice
• following tamoxifen treatment
• following tamoxifen treatment
• following tamoxifen treatment

endocrine/exocrine glands
• following tamoxifen treatment, the medullary region architecture is altered and the corticomedullary junction becomes indistinct compared to in wild-type mice
• following tamoxifen treatment, the medullary region architecture is altered and the corticomedullary junction becomes indistinct compared to in wild-type mice
• following tamoxifen treatment
• following tamoxifen treatment
• following tamoxifen treatment





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory